NovaBay enters into private placement agreement worth up to $5.3M

NovaBay Pharmaceuticals has entered into a securities purchase agreement with unnamed institutional investors worth up to $5.3 million.

Advertisement

The agreement includes private placements of series C preferred stock, series A-1 warrants and series A-2 warrants. The capital raised will be used as working capital and for general corporate purposes, according to a Sept. 9 NovaBay news release.

Ladenburg Thalmann & Co. is acting as the placement agent for the agreement.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.